JDVAX
Price
$16.47
Change
+$0.02 (+0.12%)
Updated
Aug 7 closing price
Net Assets
472.24M
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

JDVAX vs RLBCX

Header iconJDVAX vs RLBCX Comparison
Open Charts JDVAX vs RLBCXBanner chart's image
JPMorgan Diversified A
Price$16.47
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets472.24M
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
JDVAX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVAX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVAX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. JDVAX (472M). JDVAX pays higher dividends than RLBCX: JDVAX (2.35) vs RLBCX (1.56). JDVAX was incepted earlier than RLBCX: JDVAX (22 years) vs RLBCX (23 years). JDVAX (1.26) is less costly to investors than RLBCX (0.89). JDVAX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVAX: RLBCX (250) vs JDVAX (1000). JDVAX annual gain was more profitable for investors over the last year : 11.81 vs. RLBCX (11.04). RLBCX return over 5 years is better than : 34.79 vs. JDVAX (6.42).
JDVAXRLBCXJDVAX / RLBCX
Total Expense Ratio0.960.89108%
Annual Report Gross Expense Ratio1.260.89142%
Fund Existence22 years23 years-
Gain YTD7.8438.35994%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets472M253B0%
Annual Yield % from dividends2.351.56151%
Returns for 1 year11.8111.04107%
Returns for 3 years21.7329.8473%
Returns for 5 years6.4234.7918%
Returns for 10 years13.7360.6523%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAWN6.030.23
+3.97%
Day One Biopharmaceuticals
HELE21.99-0.23
-1.04%
Helen of Troy Limited
FDS386.67-5.24
-1.34%
Factset Research Systems
ASTC5.35-0.25
-4.47%
Astrotech Corp
MSPR0.74-0.08
-10.14%
MSP Recovery Inc